Thomas Stephan
Stock Analyst at Stifel Nicolaus
(3.92)
# 1,843
Out of 5,044 analysts
231
Total ratings
45.2%
Success rate
9.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Thomas Stephan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATEC Alphatec Holdings | Reiterated: Buy | $13 | $10.67 | +21.84% | 8 | Oct 7, 2026 | |
| GMED Globus Medical | Reiterated: Hold | $85 | $74.65 | +13.86% | 7 | Oct 7, 2026 | |
| SWX: ALC Alcon Inc. | Reiterated: Hold | CHF 58.15 | CHF 53.14 | +9.43% | 27 | Oct 6, 2026 | |
| GKOS Glaukos | Reiterated: Buy | $190 | $165.69 | +14.67% | 51 | Oct 2, 2026 | |
| SGP SpyGlass Pharma | Reiterated: Buy | $42 | $24.92 | +68.54% | 3 | Oct 2, 2026 | |
| STAA STAAR Surgical Company | Upgraded: Buy | $28 → $31 | $21.67 | +43.05% | 33 | Sep 29, 2026 | |
| CLPT ClearPoint Neuro | Reiterated: Buy | n/a | $10.48 | - | 6 | Sep 15, 2026 | |
| TMDX TransMedics Group | Reiterated: Hold | $65 | $77.87 | -16.53% | 19 | Sep 11, 2026 | |
| BLCO Bausch + Lomb | Reiterated: Hold | $16 | $17.30 | -7.51% | 18 | Aug 25, 2026 | |
| RXST RxSight | Reiterated: Hold | $8 → $7 | $4.81 | +45.53% | 24 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $8.89 | -10.01% | 24 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $13 | $9.17 | +41.77% | 4 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $0.89 | n/a | 7 | May 15, 2024 |
Alphatec Holdings
Oct 7, 2026
Reiterated: Buy
Price Target: $13
Current: $10.67
Upside: +21.84%
Globus Medical
Oct 7, 2026
Reiterated: Hold
Price Target: $85
Current: $74.65
Upside: +13.86%
Alcon Inc.
Oct 6, 2026
Reiterated: Hold
Price Target: CHF 58.15
Current: CHF 53.14
Upside: +9.43%
Glaukos
Oct 2, 2026
Reiterated: Buy
Price Target: $190
Current: $165.69
Upside: +14.67%
SpyGlass Pharma
Oct 2, 2026
Reiterated: Buy
Price Target: $42
Current: $24.92
Upside: +68.54%
STAAR Surgical Company
Sep 29, 2026
Upgraded: Buy
Price Target: $28 → $31
Current: $21.67
Upside: +43.05%
ClearPoint Neuro
Sep 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $10.48
Upside: -
TransMedics Group
Sep 11, 2026
Reiterated: Hold
Price Target: $65
Current: $77.87
Upside: -16.53%
Bausch + Lomb
Aug 25, 2026
Reiterated: Hold
Price Target: $16
Current: $17.30
Upside: -7.51%
RxSight
Aug 10, 2026
Reiterated: Hold
Price Target: $8 → $7
Current: $4.81
Upside: +45.53%
Aug 6, 2026
Reiterated: Buy
Price Target: $8
Current: $8.89
Upside: -10.01%
Aug 5, 2026
Reiterated: Buy
Price Target: $15 → $13
Current: $9.17
Upside: +41.77%
May 15, 2024
Reiterated: Hold
Price Target: $2
Current: $0.89
Upside: n/a